论文部分内容阅读
目的探讨中药联合胸腔镜下根治术治疗肺癌的临床疗效,为临床应用提供依据。方法随机将60例肺癌患者分为对照组和治疗组,对照组在胸腔镜下行根治术,治疗组在对照组基础上辅以中药治疗。结果术中出血量及手术时间两组比较差异无统计学意义(P>0.05),住院时间两组比较差异有统计学意义(P<0.05)。两组术后腹胀、便秘比较差异有统计学意义(P<0.05)。结论中药联合胸腔镜下根治术治疗肺癌术中可以缩短住院时间,降低术后腹胀、便秘发病率,值得临床应用。
Objective To explore the clinical efficacy of combined traditional Chinese medicine and thoracoscopic radical mastectomy in the treatment of lung cancer and provide the basis for clinical application. Methods Sixty patients with lung cancer were randomly divided into control group and treatment group. The control group underwent thoracoscopic radical mastectomy. The treatment group was treated with traditional Chinese medicine on the basis of the control group. Results The intraoperative blood loss and operation time had no significant difference between the two groups (P> 0.05). There was significant difference between the two groups in hospitalization time (P <0.05). The postoperative abdominal distension, constipation difference was statistically significant (P <0.05). Conclusion Traditional Chinese medicine combined with thoracoscopic radical mastectomy for lung cancer surgery can shorten the hospital stay and reduce postoperative bloating, constipation incidence, worthy of clinical application.